NCCS joined with 20 patient advocacy groups and professional societies to urge the Centers for Medicare and Medicaid Services (CMS) to correct a long-standing inequity in Medicare coverage by requiring Medicare Advantage plans to provide coverage for clinical trials. Currently, individuals with Medicare Advantage plans must revert to standard fee-for-service Medicare if they wish to participate in a clinical trial. The current policy is confusing and may result in higher out-of-pocket costs for enrollees who decide to participate in a clinical trial. Other enrollees will be discouraged from participating in clinical trials. NCCS and the other signatories to the letter stressed to CMS that Medicare Advantage enrollees should be given clear coverage for clinical trials services — the same as other Medicare-covered services — through their Medicare Advantage plans.
Make An Impact
The NCCS Cancer Policy & Advocacy Team (CPAT) is a program for survivors and caregivers to learn about pressing policy issues that affect quality cancer care in order to be engaged as advocates in public policy around the needs of cancer survivors.
Together we can improve cancer care for survivors! Sign up to be the first to know about cancer policy issues and ways to take action
- Get Involved
- COVID-19 Resources for Cancer Survivors
- Survivorship Checklist
- Cancer Survival Toolbox
- Survivorship Champions
- Cancer Convos Podcast
- Taking Charge of Your Care
- Care Planning for Cancer Survivors
- Tools For Care Providers
- Order Our Resources
- 2021 State of Survivorship Survey Results Briefing
- Ellen L. Stovall Award
- From Shadows to Life: A Biography of the Cancer Survivorship Movement
- Cancer Policy and Advocacy Team (CPAT) Symposium 2021
- Cancer Policy Roundtable (CPR)
- Contact Us
Copyright © 1995-2021 by the National Coalition for Cancer Survivorship
National Coalition for Cancer Survivorship, NCCS, Cancer Survival Toolbox, and related Logos are registered in the United States as trademarks of the National Coalition for Cancer Survivorship.